Lipid metabolism reprogramming is a hallmark of cancer [41–45]and we observed that SNRPB knockdown reduced triglyceride, cholesterol, and free fatty acid levels in HCC cells by downregulating key metabolic enzymes such as ACLY, FASN, and ACSL3 46, 47. The gene discussed is ACSL3; the disease is hepatocellular carcinoma.